Evidence map›Paper›PMID 37845513›Full record

ArticleNature medicine2024

Author Correction: Tau-targeting antisense oligonucleotide MAPT

Catherine J Mummery, Anne Börjesson-Hanson, Daniel J Blackburn, Everard G B Vijverberg, Peter Paul De Deyn, Simon Ducharme, Michael Jonsson, Anja Schneider, Juha O Rinne, Albert C Ludolph and 17 more

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 13 institutions in 7 countries.

Catherine J MummeryDementia Research Centre, National Hospital for Neurology and Neurosurgery, University College London, London, UK. c.mummery@ucl.ac.uk.ORCID http://orcid.org/0000-0002-6739-0803
Anne Börjesson-HansonKarolinska University Hospital, ME Aging, Stockholm, Sweden.
Daniel J BlackburnSheffield Teaching Hospital NHS Foundation Trust, NIHR Sheffield Clinical Research Facility and NIHR Sheffield Biomedical Research Centre, Royal Hallamshire Hospital, Sheffield, UK.
Everard G B VijverbergAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, the Netherlands.
Peter Paul De DeynUniversity Medical Center Groningen / RUG, Alzheimer Center Groningen, Groningen, the Netherlands.
Simon DucharmeDouglas Mental Health University Institute and McConnell Brain Imaging Centre of the Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.ORCID http://orcid.org/0000-0002-7309-1113
Michael JonssonMemory Clinic, Psychiatry - Cognition and Geriatric Psychiatry, Sahlgrenska University Hospital, Gothenburg/Molndal, Sweden.
Anja SchneiderGerman Center for Neurodegenerative Diseases, DZNE, and Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, Germany.
Juha O RinneCRST Oy; Turku PET Centre University of Turku and Turku University Hospital, Turku, Finland.ORCID http://orcid.org/0000-0001-6369-0764
Albert C LudolphDepartment of Neurology University of Ulm and DZNE, Ulm, Germany.
Ralf BodenschatzPharmakologisches Studienzentrum Chemnitz GmbH Mittweida, Mittweida, Germany.
Holly Kordasiewicz *Ionis Pharmaceuticals, Carlsbad, CA, USA.
Eric E Swayze *Ionis Pharmaceuticals, Carlsbad, CA, USA.ORCID http://orcid.org/0000-0001-6430-6576
Bethany Fitzsimmons *Ionis Pharmaceuticals, Carlsbad, CA, USA.
Laurence Mignon *Ionis Pharmaceuticals, Carlsbad, CA, USA.
Katrina M Moore *Ionis Pharmaceuticals, Carlsbad, CA, USA.
Chris Yun *Ionis Pharmaceuticals, Carlsbad, CA, USA.
Tiffany Baumann *Ionis Pharmaceuticals, Carlsbad, CA, USA.
Dan Li *Ionis Pharmaceuticals, Carlsbad, CA, USA.
Daniel A Norris *Ionis Pharmaceuticals, Carlsbad, CA, USA.ORCID http://orcid.org/0000-0003-2074-5862
Rebecca Crean *Ionis Pharmaceuticals, Carlsbad, CA, USA.
Danielle L Graham *Biogen, Cambridge, MA, USA.
Ellen Huang *Biogen, Cambridge, MA, USA.
Elena Ratti *Biogen, Cambridge, MA, USA.
C Frank Bennett *Ionis Pharmaceuticals, Carlsbad, CA, USA.
Candice JungeIonis Pharmaceuticals, Carlsbad, CA, USA.
Roger M LaneIonis Pharmaceuticals, Carlsbad, CA, USA.
Ionis Pharmaceuticals (United States) · USBiogen (United States) · USAmsterdam Neuroscience · NLDouglas Mental Health University Institute · CAHochschule Mittweida · DEKarolinska University Hospital · SERoyal Hallamshire Hospital · GBSahlgrenska University Hospital · SEUK Dementia Research Institute · GBUniversität Ulm · DEUniversity Hospital Bonn · DEUniversity Medical Center Groningen · NLUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37845513
PMCPMC10803246
OpenAlexW4387673858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.